- Home
- ASR vs AXSM Comparison
ASR vs AXSM Comparison
Compare ASR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASR | AXSM |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | Mexico | United States |
| Employees | 1936 | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 9.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | ASR | AXSM |
|---|---|---|
| Price | $336.36 | $167.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 17 |
| Target Price | ★ $365.00 | $210.65 |
| AVG Volume (30 Days) | 65.3K | ★ 491.7K |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 11.14% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.13 | $58.18 |
| Revenue Next Year | $8.74 | $55.45 |
| P/E Ratio | $18.58 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $249.21 | $86.99 |
| 52 Week High | $381.52 | $191.50 |
Technical Indicators
Market Signals| Indicator | ASR | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 51.89 |
| Support Level | $317.21 | $151.26 |
| Resistance Level | $348.98 | $169.11 |
| Average True Range (ATR) | 10.17 | 5.36 |
| MACD | 2.19 | 1.69 |
| Stochastic Oscillator | 50.22 | 63.94 |
Price Performance
Historical ComparisonAbout ASR Grupo Aeroportuario del Sureste S.A. de C.V.
Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The group's operating segments are Cancun, which generates maximum revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.